Results:
Research Roundtables
View Other Research Roundtables
July 23-24 – Washington, DC
Opportunities and Challenges in the Myeloma Drug Development Process
Objective
To identify real and perceived obstacles to future myeloma drug approvals and develop solutions to overcome them.
Sponsors
The following organizations contributed valuable support for this event: Celgene Corporation, Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., Millennium Pharmaceuticals The Takeda Oncology Company, Centocor Ortho Biotech Services LLC, and Keryx Biopharmaceuticals, Inc.
